ETHZilla Corp
NASDAQ:ETHZ
ETHZilla Corp
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California. The company went IPO on 2017-06-07. This strategy is built for the community, by the community. Through its partnership with Electric Capital, ETHZilla's treasury strategy aims to pursue a differentiated yield generation program meant to outperform traditional ETH staking. The firm has also been evolving its business towards software-enabled gaming and entertainment. In addition to its ETH treasury strategy, the Company continues to maintain and accelerate the deployment and development of its gaming initiatives.
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California. The company went IPO on 2017-06-07. This strategy is built for the community, by the community. Through its partnership with Electric Capital, ETHZilla's treasury strategy aims to pursue a differentiated yield generation program meant to outperform traditional ETH staking. The firm has also been evolving its business towards software-enabled gaming and entertainment. In addition to its ETH treasury strategy, the Company continues to maintain and accelerate the deployment and development of its gaming initiatives.
Transformational Quarter: ETHZilla completed its rebrand and pivot from biotech to Ethereum-based digital asset management, raising $931 million in new financing.
First Revenue Reported: Q3 revenue reached $4.1 million, generated from staking yields and incentive tokens—marking the company’s first revenue after its strategic shift.
Significant Asset Growth: Total assets surged to $1.01 billion from $12.8 million at year-end 2024.
Tokenization Roadmap: ETHZilla expects to launch its first tokenized real-world assets on Liquidity.io within weeks, targeting asset classes like aerospace, consumer credit receivables, and real estate.
Yield Strategy: Average annualized yield on staked ETH was 7% in Q3, with Q4 yield guidance of 3.5%–4.5% as activities normalize.
Share Buybacks: Repurchased 2.1 million shares since September 1 for $46.3 million, citing confidence in long-term value.
